1 June 2021

Celtarys Research is attending BIODIGITAL 21

BIODIGITAL 21, the international meeting focused on biotechnology, is just around the corner and our CEO Sonia Martinez Arca will be present in the event. BIODIGITAL […]
31 August 2021

Trends in kinase drug discovery: targets, indications and inhibitor design

Abstract: The FDA approval of imatinib in 2001 was a breakthrough in molecularly targeted cancer therapy and heralded the emergence of kinase inhibitors as a key […]
31 August 2021

Celtarys Research is attending BIOSPAIN 2021

BIOSPAIN, the international meeting focused on biotechnology, is just around the corner and our BD Team will be present in the event. With more than 3,000 […]
6 September 2021

Celtarys Research has been one of the finalists of the 2021 RSC Emerging Technologies Competition

The Emerging Technologies Competition is the Royal Society of Chemistry’s annual initiative for early-stage companies and academic entrepreneurs who want to commercialise their technologies to make […]
14 September 2021

Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia

Impressive paper published in Nature journal tackling allosteric modulation of adenosine A1 receptor (A1R) as a promising therapeutic approach of non-opioid analgesic agents to treat neuropathic pain. […]